- BBS Pharmaceuticals Contact
- contact@bbspharmaceuticals.com
BBS Pharmaceuticals News
[display-posts include_excerpt=”true” excerpt_length=”20″ image_size=”thumbnail” wrapper=”div” wrapper_class=”display-posts-listing image-left”]
July 18, 2020
BBS Pharmaceuticals, a licensed cultivator and manufacturer of medicinal cannabis products would like to congratulate Minister David Littleproud and the Australian Parliament in passing the Export […]
June 18, 2020
It has been a busy and productive start of the second quarter here at BBS Pharmaceuticals. We had the honour to welcome local Member of Hammond, […]
June 11, 2020
It has been a busy and incredibly productive start of the week here at BBS as we are entering the second half of the year. This […]
June 4, 2020
It has been a busy and productive start of the second quarter here at BBS Pharmaceuticals. We had the honour to welcome local Member of Hammond, […]
May 28, 2020
It was our great honour to host The Hon. David Ridgway, Minister of Trade and Investment, at BBS’s cultivation and production facility. Together with BBS’s Corporate […]
April 30, 2020
Australia has published a framework for new CBD regulations as it considers relaxing its narcotics scheduling of cannabidiol to make it available over the counter in […]
April 23, 2020
Michael Kromwyk has been appointed Head of Sales and Marketing at BBS Pharmaceuticals with responsibility for brand and marketing programs, sales strategy, growing product sales, partnering […]
April 23, 2020
These are challenging times as the world responds to the coronavirus outbreak and sets a path to recovery. First off, our hearts go out to anyone […]
April 14, 2020
As various phases of legalisation come into effect in different parts of Australia, the country’s cannabis market is expected to break through the barrier of US$1.5 […]